Alan Dunton
Non-Executive Director / Cambium Bio
| Rank | Company | 1 Yr | 5 Yr |
|---|---|---|---|
| 816th | Atlas Arteria | 12.43% | 3.2% |
| 817th | Ophir High Conviction Fund | 12.43% | 1.93% |
| 818th | Recce Pharmaceuticals | 12.42% | -14.83% |
| 819th | Lovisa Holdings | 12.33% | 29.03% |
| 820th | JB Hi-Fi | 11.98% | 23.42% |
| NEW ROLE: Non-Executive Director, Cambium Bio | 03 Nov 2020 | |
| NEW ROLE: Non-Executive Director, Recce Pharmaceuticals | 18 Aug 2020 |
Access to our data for Alan Dunton is only available to paid subscribers with Data & Insights access.
Data & Insights is Western Australia's most accurate and comprehensive business listings and searchable database.
Alan Dunton is linked to 2 organisations which are included in 1 list - Public Companies - non WA.
To see the data you will need to Subscribe.